Clinical Impact of Implementing a Specific Clinical Pathway for the Management of Clostridioides difficile Infection
[Introduction] Despite Clostridioides difficile infection (CDI) being a leading healthcare-associated infection with high morbimortality, there is little evidence on specific antimicrobial stewardship program (ASP) interventions for CDI. The objective of this study was to assess the clinical impact...
| Autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2026 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/420363 |
| Acceso en línea: | http://hdl.handle.net/10261/420363 https://api.elsevier.com/content/abstract/scopus_id/105021130315 |
| Access Level: | acceso abierto |
| Palabra clave: | Clostridioides difficile Clinical pathway Health plan implementation Hospital admission Mortality Recurrence |
| Sumario: | [Introduction] Despite Clostridioides difficile infection (CDI) being a leading healthcare-associated infection with high morbimortality, there is little evidence on specific antimicrobial stewardship program (ASP) interventions for CDI. The objective of this study was to assess the clinical impact of implementing a specific clinical pathway for CDI management at two Spanish hospitals. |
|---|